UV application to organize the first quarter 2022 conference call on May 24, 2022

Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen removal technology company that applies the power of narrow range ultraviolet (“UVC”) light to surfaces and air-purifying catalytic bioconversion technology to destroy pathogens safely, completely and automatically, announced that the company will host an investor conference call and live webcast on Tuesday, May 24, 2022 at 9:00 a.m. HE to review its financial results. First quarter 2022 financial results to be released after market close on Monday, May 23 rd and will be available through the Investor Relations section of the Company’s website at https://irdirect.net/AUVI.

Conference Call/Webcast Information

The Applied UV management team will host an investor conference call and live webcast on May 24, 2022 at 9:00 a.m. ET. Investors can access the live webcast via a link on the Applied UV website at https://www.webcaster4.com/Webcast/Page/2626/45615. For those planning to join the call, please dial +1-877-545-0320 (for domestic calls) or +1-973-528-0002 (for international calls), passcode 867374 A replay of the conference call will be available online on the Applied UV website, and a replay will be available for one week after the call at +1-877-481-4010 (for domestic calls) or at +1-919-882-2331 (for international calls), listen again to access code 45615.

About Applied UVs

Applied UV is focused on developing and acquiring technologies that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries – SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s Connected Platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, completely and automatically, addressing the challenge of hospital-acquired infections (“HAI”). Intended for use in high customer turnover facilities such as hospitals, hotels, commercial facilities and other public spaces, the company’s Lumicide™ platform uses UVC LEDs in several patented designs for the infection control in and around high traffic areas, including sinks and toilets, killing bacteria, viruses and other pathogens residing on hard surfaces near appliances. The company’s patented drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical, pathogen-intensive location. SteriLumen’s Airocide® air purifying devices are research backed, clinically proven and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II medical device, uses proprietary photocatalytic bioconversion (PCO) technology that draws air into a reaction chamber that converts harmful molds, microorganisms, pathogens into airborne, destructive VOCs, allergens, odors and bio-gases into harmless water vapor and green carbon dioxide without producing ozone or other harmful by-products. Airocide® applications include healthcare, hospitality, grocery chains, winemaking facilities, commercial real estate, schools, dental offices, post-harvest, grocery stores, facilities of cannabis and houses. For more information about Applied UV, Inc. and its affiliates, please visit the following website: https://www.applieduvinc.com/.

Forward-looking statements

The information contained in this document may contain “forward-looking statements”. Forward-looking statements reflect current beliefs about future events. When used in this press release, the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements in this press release regarding Applied UV’s management views regarding its business strategy, future results of operations and outlook for cash and capital resources. Forward-looking statements are based on the Company’s current expectations and assumptions regarding its business, economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical facts nor guarantees of future performance. We therefore caution you against relying on any of these forward-looking statements. Factors or events that could cause the Company’s actual results to differ may arise from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including United States securities laws, the Company does not intend to update forward-looking statements to conform them to actual results.

For additional company information:
Applied UV Inc.
John F. Andrews
CEO/Director
[email protected]

Contact:
Brett Maas, General Manager
R.I. Hayden
[email protected]
(646) 536-7331

Michael P. Boser